
Mircera 100mcg/0.3ml Injection
Mircera 100mcg/0.3ml Injection is a long-acting clinical treatment for anemia in chronic kidney disease, available through PakMeds for specialized home delivery.
| Manufacturer | Roche Pharmaceuticals |
| Active Ingredients | Methoxy Polyethylene Glycol-epoetin Beta |
| Medicine Strength | 100mcg/0.3ml |
| Number Per Pack | 1 Pre-filled Syringe |
| Requires Prescription? | Yes |
| Generics | Continuous Erythropoietin Receptor Activator (CERA) |
Mircera 100mcg/0.3ml Injection Ingredients and Usage
Mircera 100mcg is a Continuous Erythropoietin Receptor Activator (CERA). It is clinically utilized for the treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients, whether they are on dialysis or not. This advanced formulation is designed to maintain stable hemoglobin levels with less frequent dosing compared to traditional erythropoietins. PakMeds ensures that this sensitive biologic medication is delivered under strict cold-chain protocols to support patients with renal-related anemia.
How Does Mircera 100mcg/0.3ml Injection Work?
The active ingredient is a synthetic erythropoietin conjugated with a polyethylene glycol chain. It works by interacting with the erythropoietin receptors on progenitor cells in the bone marrow. By stimulating these receptors, Mircera promotes the production, maturation, and survival of red blood cells. Its unique molecular structure results in a much longer half-life and slower degradation, allowing for once-monthly or twice-monthly administration while maintaining a steady therapeutic effect on red blood cell counts.
Mircera 100mcg/0.3ml Injection Side Effects
The most common side effect is hypertension (high blood pressure). Other potential side effects include headache, vascular access thrombosis (in dialysis patients), and diarrhea. Rare but serious complications include Pure Red Cell Aplasia (PRCA) and severe skin reactions.
List of Warnings:
- Blood pressure must be adequately controlled before and during treatment.
- Regular monitoring of hemoglobin levels is required; rapid rises increase the risk of cardiovascular events.
- Use with caution in patients with a history of seizures or chronic liver disease.
- Should be administered via intravenous or subcutaneous injection by a healthcare professional.
Mircera 100mcg/0.3ml Injection Storage Conditions
Mircera must be stored in a refrigerator between 2°C and 8°C. Do not freeze the product and keep the pre-filled syringe in its original carton to protect it from light. A single period of room temperature storage (up to 25°C) for no more than one month is acceptable.
Reviews
There are no reviews yet.
(0 customer reviews)